Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$25,527,116
+$2,698,714 QoQ
Shares Held
101,443
-3.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.86%
of 13F equity value
Holder Rank
#533
of 4,150 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hikari Tsushin, Inc. holds $60,254,195 across 7 Drug Manufacturers - General names. ABBV ranks #2 (42.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
109,067 | $27,699,745 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
101,443 | $25,527,116 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
81,141 | $4,675,344 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,812 | $1,132,342 | |
| 5 | NVO |
Novo Nordisk A S
|
23,512 | $1,127,165 | |
| 6 | AMGN |
Amgen Inc
|
233 | $84,373 | |
| 7 | OGN |
Organon & Co.
|
599 | $8,110 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,527,116 | 101,443 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $22,828,402 | 104,963 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $23,982,995 | 104,963 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $24,303,133 | 104,963 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $19,483,232 | 104,963 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $21,991,847 | 104,963 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $18,651,925 | 104,963 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $20,728,093 | 104,963 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $18,003,253 | 104,963 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $19,113,762 | 104,963 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $16,266,116 | 104,963 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $15,645,784 | 104,963 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $14,830,674 | 110,077 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $17,542,971 | 110,077 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $17,789,543 | 110,077 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $14,773,434 | 110,077 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $16,859,393 | 110,077 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $17,844,582 | 110,077 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $14,904,425 | 110,077 | Shares | Sole | 2022-02-08 | |
| 2021-06-30 | $12,629,084 | 112,119 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $5,250,834 | 48,520 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $994,352 | 9,280 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||